Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Actas Dermo-Sifiliograficas|December 25, 2025
Translation, cross-cultural adaptation, correlation with other PROMs and validation of the MF/SS-CTCL-QoL questionnaire on quality of life in mycosis fungoides (MF) and Sézary syndrome (SS)M M Onteniente-Gomis, S I Palencia Perez, F J Ortiz de Frutos, et al.The American Journal of Pathology|May 4, 2000
p16(INK4a) gene alterations are frequent in lesions of mycosis fungoidesI C Navas, P L Ortiz-Romero, R Villuendas, et al.The British Journal of Dermatology|October 24, 2008
Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathwaysM B Wozniak, L Tracey, P L Ortiz-Romero, et al.Dermatology (Basel, Switzerland)|August 18, 2011
Necrosis of ears after use of cocaine probably adulterated with levamisoleI de la Hera, V Sanz, D Cullen, et al.The British Journal of Dermatology|February 24, 2012
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous LymphomaY Peñate, B Hernández-Machín, L I Pérez-Méndez, et al.The British Journal of Dermatology|June 17, 2021
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivityE Papadavid, E Kapniari, V Pappa, et al.The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2020
Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic featuresW Kempf, C Mitteldorf, M Battistella, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 10, 2017
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, BiobadadermI Belinchón, J M Ramos, G Carretero, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 9, 2019
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous LymphomaR Fernández-de-Misa, B Hernández-Machín, A Combalía, et al.Pageof 5